Drug Class
HCV NS5A inhibitor and NS5B polymerase inhibitor
Type
brand
Active Ingredient
ledipasvir/sofosbuvir
📋Overview
Harvoni is a combination medication that contains ledipasvir and sofosbuvir. It is primarily used in the management of chronic hepatitis C virus (HCV) infection. Harvoni works by targeting specific proteins involved in the replication of the hepatitis C virus, helping to reduce the amount of virus in the body. This medication is associated with efforts to improve liver health and prevent complications related to chronic hepatitis C.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Harvoni
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.
